Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study.
Ye SL, Chen X, Yang J, Bie P, Zhang S, Liu F, Liu L, Zhou J, Dou K, Hao C, Shao G, Xia Q, Chen Y, Yang J, Deng X, Liu Y, Yuan Y, Fu Z, Nakajima K, Yip CS, Lu Z.
Ye SL, et al.
Oncotarget. 2016 Feb 9;7(6):6639-48. doi: 10.18632/oncotarget.6781.
Oncotarget. 2016.
PMID: 26735891
Free PMC article.
Clinical Trial.